Blog

Oscar Tahuahua: ctDNA could offer hope for NSCLC management

ox.ac.uk/new

Jan 23, 2025, 14:32

Oscar Tahuahua: ctDNA could offer hope for NSCLC management

Oscar Tahuahua, Medical Oncology Fellow at National Cancer Institute (Mexico), shared an article by Nicola Normanno et al. on X:

“ctDNA in NSCLC provides a powerful tool for MRD detection, relapse stratification, and treatment monitoring. Its utility is established, but clinical integration depends on standardized assays, sensitivity, and validation.”

Circulating tumour DNA in early-stage and locally advanced NSCLC: ready for clinical implementation?

Authors: Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, Vincenzo Sforza, Lorenza Landi, Emilio Bria, Angelo Delmonte, Federico Cappuzzo & Antonella De Luca

Alessandro Morabito Angelo Delmonte Anna Maria Rachiglio Antonella De Luca cancer cancer monitoring Cancer research clinical integration ctDNA Emilio Bria Federico Cappuzzo Lorenza Landi Lung cancer molecular profiling MRD detection Nicola Normanno NSCLC OncoDaily Oncology Oscar Tahuahua relapse stratification treatment advancements Vincenzo Sforza

Agenus announced new data highlighting BOT/BAL across multiple lines of treatment in Colorectal Cancer

OncoDaily Acquires CancerWorld: A New Era in Oncology Media

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director